Since we consistently found that Dex treatment induced a more robust modulation of LEDGF/p75 protein expression than cortisol in our PCa cellular models, all subsequent experiments were conducted with Dex, a highly specific and potent GR agonist84. This evidence concerns the gene NR3C1 and posterior cortical atrophy.